Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-05-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients
NCT01617343
OKS for Gait Instability
NCT03579186
Biofeedback for Hemianopia Vision Rehabilitation
NCT05397873
OCT Eccentric Fixation and Amblyopia in Children
NCT05714449
Visual Rehabilitation After Occipital Stroke
NCT04798924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Optimization of OKS
Crossover study examining various OKS protocols on improving symptoms of hemispatial neglect
OKS
Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
Safety and efficacy study
Randomized study assessing the safety and efficacy of OKS in treating hemispatial neglect
OKS
Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
Effect of repetitive stimulation
Benefits of daily, repetitive OKS in treating hemispatial neglect
OKS
Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
OKS and gait
Effect of OKS on gait and balance
OKS
Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OKS
Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Documented vestibular disorder
21 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
National Eye Institute (NEI)
NIH
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chun Lim
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chun Lim, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016P000396
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.